Longevity Consortium Administrative Core supports national aging research collaboration
Official title: Longevity Consortium Administrative Core
Funded at Translational Genomics Research Inst · NIH-11399382 · Data updated 2026-11-12
A central Administrative Core coordinates and communicates about a large aging research collaboration and helps share data and results with scientists and the public.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Translational Genomics Research Inst NIH-funded |
| Lab location | 1 site (Phoenix, United States) |
| Project start | September 30, 2004 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $978,978 |
| NIH project number | 5U19AG023122-18 |
| Project ID | NIH-11399382 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not a patient-facing study; this grant supports collaboration that could enable future translational research involving people.
✕Less likely to help
There is no direct patient participation in this Administrative Core grant.
What this research studies
This grant funds the Administrative Core of the Longevity Consortium, a team-based effort to organize five research projects and supporting cores. It focuses on leadership, coordination, outreach, and data sharing through platforms like Synapse and ELITE Portal. The core also plans annual meetings, oversees multiple advisory groups, and ensures timely, high-quality progress toward long-term aging research goals. The work is designed to benefit researchers and, ultimately, patients by enabling collaboration and access to results.
Why it matters
Potential benefit: Strengthened collaboration and faster dissemination of aging research findings that could inform future patient-oriented studies.
How similar studies have gone: Large, multi-project consortia with strong administrative cores have successfully accelerated aging research and data sharing in the past.
Where this research is happening
-
Translational Genomics Research Inst
Phoenix, United States Active
Researchers
- Principal investigator: Schork, Nicholas Joseph — Translational Genomics Research Inst
- Study coordinator: Schork, Nicholas Joseph
Related research
Other NIH-funded projects on the same topics.
-
CLU's role in Alzheimer's disease pathogenesis
Researchers are studying how the CLU gene may drive brain changes in Alzheimer's disease and how targeting CLU could lead to safer treatments.
-
How glioblastoma changes across the tumor and over time during treatment
This work maps how glioblastoma tumors shift their cell types and interactions during and after treatment to find weaknesses that could help people with recurrent GBM.
-
Understanding how early changes in lungs lead to progressive fibrotic disease
This grant studies the cells and genes involved in starting and advancing pulmonary fibrosis to uncover why some people progress to severe disease.
-
Integrative Analysis Core for Longevity and Dementia Research
A broad, shared analysis resource aims to bring together multiple studies on aging, longevity, and Alzheimer’s disease to better understand how genetics and other factors influence healthy aging.
-
Understanding Why Some People Age Well Despite Alzheimer’s and Related Dementias
Researchers are building patient-derived cell models to study why some people resist or slow down dementia and how aging affects brain cells, with a focus on Alzheimer’s Disease and related disorders.
-
Drugs that slow aging and extend healthy years
A research project aims to find and test medicines that could slow aging and help people stay healthier longer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.